Work

Disease stabilization versus response after bevacizumab treatment in recurrent ovarian cancer: How do we determine clinical efficacy?

Year: 2015

Type: article

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2015.01.130

Authors: K.C. Fuh, A.A. Secord, K.S. Bevis, W.K. Huh, K. Blansit, E. Rosenfeld, L. Hu, R.A. Previs, A.B. Gardner, D.S. Kapp, J.K. Chan

Institutions: Washington University in St. Louis, Duke University, Duke Medical Center, University of Alabama at Birmingham, Palo Alto Medical Foundation, California Pacific Medical Center, The University of Texas MD Anderson Cancer Center, Stanford University

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2098564859

FWCI: 0.381

Cites:

Cited by: 1

Related to: 10